Please assess the completion status of the following clinical trial:

Trial Title: Transmyocardial Laser Revascularization and Cardiovascular Magnetic Resonance Imaging

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female 18 years of age or over~* Patients with medically refractory, severe, class III or IV angina based on the Canadian Cardiovascular Society angina scale as determined by a physician~* Ejection fraction 25% or greater~* Patients with significant ischemia in the myocardium and who are NOT candidates for treatment by direct coronary revascularization methods (i.e., CABG or PCI)~* Ability and willingness to consent and Authorization for use of PHI~Exclusion Criteria:~* Patient cannot undergo a surgical procedure or general anesthesia~* Patient not eligible for CMR study~* Severe unstable angina~* Q-wave MI within 3 weeks prior to TMR~* NQWMI within 2 weeks prior to TMR~* Decompensated heart failure (class III/IV) at the time of procedure~* Known increased bleeding risk~* Implanted pacemaker or defibrillator~* Clinically unstable arrhythmia~* Not able or willing to adhere to the study tests and procedures~* Inability or unwillingness to consent and Authorization for use of PHI

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- All Patients (Type: OTHER): All patients undergo the same study procedures

Based on this trial design, predict the completion outcome and termination type (if applicable).